Standard BioTools Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -62.6% | -62.6% | -21.5% |
| FY2022 | 233.3% | 1,146.9% | -48.7% |
| FY2023 | 50.4% | 88.3% | -23.1% |
| FY2024 | -29.4% | -29.4% | -22.7% |
| FY2025 | -17.7% | -17.7% | -13.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -62.6% | -62.6% | -21.5% |
| FY2022 | 233.3% | 1,146.9% | -48.7% |
| FY2023 | 50.4% | 88.3% | -23.1% |
| FY2024 | -29.4% | -29.4% | -22.7% |
| FY2025 | -17.7% | -17.7% | -13.2% |